Global Medical Marijuana Market research

Medical Marijuana Comprehensive Study by Type (Buds, Oil, Tinctures), Application (Chronic Pain, Mental Disorders, Arthritis, Migraine, Cancer, Other), Marijuana Type (Medical Marijuana, Recreational Marijuana) Players and Region - Global Market Outlook to 2030

Medical Marijuana Market by XX Submarkets | Forecast Years 2024-2030 | CAGR: 20.25%  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
About Medical Marijuana
Medical marijuana is also called as medical cannabis, cannabis. Medical marijuana is just a marijuana plant that is treated to get composition of cannabinoids, which is essential to produce a product to be in use. Cannabinoids that are suggested by doctors for their patients. Medical marijuana is typically found in two forms dried and extract. The use of cannabis as drug has not been rigorously verified due to creation restrictions as well as other governmental regulations. Cannabinoids are generally intended to form a specific medicine to treat disorders such as cancer, anxiety, AIDS, nerve damage, epilepsy, PTSD, and arthritis.

AttributesDetails
Study Period2018-2030
Base Year2023
UnitValue (USD Million)
CAGR20.25%


Global Medical Marijuana market is still in the introduction phase in healthcare industry. The United States and Canada are moving towards legalization of marijuana for recreational purposes. Thus, the North American medical marijuana market is highly concentrated. Moreover, legalization of marijuana in other developing countries will increase the accessibility and favorable environments for the new entrants. Countries including Germany and Australia are predicted to develop as leading markets in terms of sale, whereas, countries like Israel are focusing on research and development. Analyst at AMA Research estimates that Canadian Players will contribute the maximum growth to Global Medical Marijuana market throughout the forecasted period. Established and emerging Players should take a closer view at their existing organizations and reinvent traditional business and operating models to adapt to the future.

GW Pharmaceuticals PLC. (United Kingdom), MedReleaf Corporation (Canada), Canopy Growth Corporation (Canada), Aphria Incorporation (Canada), Aurora Cannabis Inc. (Canada), Medical Marijuana, Inc. (United States), Green Relief Inc. (Canada), Cannabis Sativa, INC. (United States) and Insys Therapeutics, Inc. (United States) are some of the key players that are part of study coverage. Additionally, the Players which are also part of the research coverage are Maricann Group, Inc. (Canada), Tilray (Canada), The Cronos Group (Canada) and Organigram Holdings, Inc. (Canada).

Segmentation Overview
AMA Research has segmented the market of Global Medical Marijuana market by Type (Buds, Oil and Tinctures), Application (Chronic Pain, Mental Disorders, Arthritis, Migraine, Cancer and Other) and Region.



On the basis of geography, the market of Medical Marijuana has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). North America region held largest market share in the year 2023. If we see Market by Marijuana Type, the sub-segment i.e. Medical Marijuana will boost the Medical Marijuana market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.

Influencing Trend:
Emergence of Luxury Cannabis Products and Increasing Number of Medical Marijuana Clubs

Market Growth Drivers:
Rising Chronical Diseases, High Adoption for Treatment of Neurological Disorders and High Public and Private Investments in Research and Developments

Challenges:
Straighten Government Regulations

Restraints:
High Price of Cannabis Testing Products and Difficulty in Procurement of License for Production

Opportunities:
Legalization of Medical Marijuana in Emerging Countries and Increasing Research and Development Related Medical Marijuana

Market Leaders and their expansionary development strategies
In January 2024, Aurora Cannabis Inc. launched three new cannabis-infused beverages. These products were initially available exclusively to Aurora's veteran patients and included THC, CBD, and CBG offerings.
In August 2020, FARMACEUTICALRX announced the launch of its new medical marijuana brand - Burst of Wellness - targeting quality and value-focused patients. The product portfolio initially launched with a selection of vape cartridges.
The federal government’s view of medical marijuana is evolving as the U.S. Food and Drug Administration (“FDA” or “Agency”), on June 25, 2018, approved Epidiolex, the first drug containing cannabidiol (“CBD”), a marijuana derivative, and the U.S. Congress considers several bills aimed at relaxing regulatory standards for medical marijuana. In a press release regarding this recent approval, FDA Commissioner Scott Gottlieb reiterated the Agency’s commitment to “careful scientific research and development,” noting that the “approval serves as a reminder that advancing sound development programs that properly evaluate active ingredients contained in marijuana can lead to important medical therapies.” Before Epidiolex can be made available to patients, CBD must be rescheduled by the U.S. Drug Enforcement Administration (“DEA”) from its current Schedule I classification under the Controlled Substances Act (“CSA”).

Key Target Audience
Medical Marijuana Providers, Medical Marijuana Suppliers, Healthcare Industry, Industry Associations and Experts, Private Research Organizations and Consulting Companies, Industry Associations, Government Market Research and Consulting Firm and Others

About Approach
To evaluate and validate the market size various sources including primary and secondary analysis is utilized. AMA Research follows regulatory standards such as NAICS/SIC/ICB/TRCB, to have a better understanding of the market. The market study is conducted on basis of more than 200 companies dealing in the market regional as well as global areas with the purpose to understand the companies positioning regarding the market value, volume, and their market share for regional as well as global.

Further to bring relevance specific to any niche market we set and apply a number of criteria like Geographic Footprints, Regional Segments of Revenue, Operational Centres, etc. The next step is to finalize a team (In-House + Data Agencies) who then starts collecting C & D level executives and profiles, Industry experts, Opinion leaders, etc., and work towards appointment generation.

The primary research is performed by taking the interviews of executives of various companies dealing in the market as well as using the survey reports, research institute, and latest research reports. Meanwhile, the analyst team keeps preparing a set of questionnaires, and after getting the appointee list; the target audience is then tapped and segregated with various mediums and channels that are feasible for making connections that including email communication, telephonic, skype, LinkedIn Group & InMail, Community Forums, Community Forums, open Survey, SurveyMonkey, etc.

Report Objectives / Segmentation Covered

By Type
  • Buds
  • Oil
  • Tinctures
By Application
  • Chronic Pain
  • Mental Disorders
  • Arthritis
  • Migraine
  • Cancer
  • Other
By Marijuana Type
  • Medical Marijuana
  • Recreational Marijuana

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Rising Chronical Diseases
      • 3.2.2. High Adoption for Treatment of Neurological Disorders
      • 3.2.3. High Public and Private Investments in Research and Developments
    • 3.3. Market Challenges
      • 3.3.1. Straighten Government Regulations
    • 3.4. Market Trends
      • 3.4.1. Emergence of Luxury Cannabis Products
      • 3.4.2. Increasing Number of Medical Marijuana Clubs
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Medical Marijuana, by Type, Application, Marijuana Type and Region (value, volume and price ) (2018-2023)
    • 5.1. Introduction
    • 5.2. Global Medical Marijuana (Value)
      • 5.2.1. Global Medical Marijuana by: Type (Value)
        • 5.2.1.1. Buds
        • 5.2.1.2. Oil
        • 5.2.1.3. Tinctures
      • 5.2.2. Global Medical Marijuana by: Application (Value)
        • 5.2.2.1. Chronic Pain
        • 5.2.2.2. Mental Disorders
        • 5.2.2.3. Arthritis
        • 5.2.2.4. Migraine
        • 5.2.2.5. Cancer
        • 5.2.2.6. Other
      • 5.2.3. Global Medical Marijuana by: Marijuana Type (Value)
        • 5.2.3.1. Medical Marijuana
        • 5.2.3.2. Recreational Marijuana
      • 5.2.4. Global Medical Marijuana Region
        • 5.2.4.1. South America
          • 5.2.4.1.1. Brazil
          • 5.2.4.1.2. Argentina
          • 5.2.4.1.3. Rest of South America
        • 5.2.4.2. Asia Pacific
          • 5.2.4.2.1. China
          • 5.2.4.2.2. Japan
          • 5.2.4.2.3. India
          • 5.2.4.2.4. South Korea
          • 5.2.4.2.5. Taiwan
          • 5.2.4.2.6. Australia
          • 5.2.4.2.7. Rest of Asia-Pacific
        • 5.2.4.3. Europe
          • 5.2.4.3.1. Germany
          • 5.2.4.3.2. France
          • 5.2.4.3.3. Italy
          • 5.2.4.3.4. United Kingdom
          • 5.2.4.3.5. Netherlands
          • 5.2.4.3.6. Rest of Europe
        • 5.2.4.4. MEA
          • 5.2.4.4.1. Middle East
          • 5.2.4.4.2. Africa
        • 5.2.4.5. North America
          • 5.2.4.5.1. United States
          • 5.2.4.5.2. Canada
          • 5.2.4.5.3. Mexico
    • 5.3. Global Medical Marijuana (Volume)
      • 5.3.1. Global Medical Marijuana by: Type (Volume)
        • 5.3.1.1. Buds
        • 5.3.1.2. Oil
        • 5.3.1.3. Tinctures
      • 5.3.2. Global Medical Marijuana by: Application (Volume)
        • 5.3.2.1. Chronic Pain
        • 5.3.2.2. Mental Disorders
        • 5.3.2.3. Arthritis
        • 5.3.2.4. Migraine
        • 5.3.2.5. Cancer
        • 5.3.2.6. Other
      • 5.3.3. Global Medical Marijuana by: Marijuana Type (Volume)
        • 5.3.3.1. Medical Marijuana
        • 5.3.3.2. Recreational Marijuana
      • 5.3.4. Global Medical Marijuana Region
        • 5.3.4.1. South America
          • 5.3.4.1.1. Brazil
          • 5.3.4.1.2. Argentina
          • 5.3.4.1.3. Rest of South America
        • 5.3.4.2. Asia Pacific
          • 5.3.4.2.1. China
          • 5.3.4.2.2. Japan
          • 5.3.4.2.3. India
          • 5.3.4.2.4. South Korea
          • 5.3.4.2.5. Taiwan
          • 5.3.4.2.6. Australia
          • 5.3.4.2.7. Rest of Asia-Pacific
        • 5.3.4.3. Europe
          • 5.3.4.3.1. Germany
          • 5.3.4.3.2. France
          • 5.3.4.3.3. Italy
          • 5.3.4.3.4. United Kingdom
          • 5.3.4.3.5. Netherlands
          • 5.3.4.3.6. Rest of Europe
        • 5.3.4.4. MEA
          • 5.3.4.4.1. Middle East
          • 5.3.4.4.2. Africa
        • 5.3.4.5. North America
          • 5.3.4.5.1. United States
          • 5.3.4.5.2. Canada
          • 5.3.4.5.3. Mexico
    • 5.4. Global Medical Marijuana (Price)
      • 5.4.1. Global Medical Marijuana by: Type (Price)
  • 6. Medical Marijuana: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2023)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. GW Pharmaceuticals PLC. (United Kingdom)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. MedReleaf Corporation (Canada)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Canopy Growth Corporation (Canada)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Aphria Incorporation (Canada)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Aurora Cannabis Inc. (Canada)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Medical Marijuana, Inc. (United States)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Green Relief Inc. (Canada)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Cannabis Sativa, INC. (United States)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Insys Therapeutics, Inc. (United States)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
  • 7. Global Medical Marijuana Sale, by Type, Application, Marijuana Type and Region (value, volume and price ) (2025-2030)
    • 7.1. Introduction
    • 7.2. Global Medical Marijuana (Value)
      • 7.2.1. Global Medical Marijuana by: Type (Value)
        • 7.2.1.1. Buds
        • 7.2.1.2. Oil
        • 7.2.1.3. Tinctures
      • 7.2.2. Global Medical Marijuana by: Application (Value)
        • 7.2.2.1. Chronic Pain
        • 7.2.2.2. Mental Disorders
        • 7.2.2.3. Arthritis
        • 7.2.2.4. Migraine
        • 7.2.2.5. Cancer
        • 7.2.2.6. Other
      • 7.2.3. Global Medical Marijuana by: Marijuana Type (Value)
        • 7.2.3.1. Medical Marijuana
        • 7.2.3.2. Recreational Marijuana
      • 7.2.4. Global Medical Marijuana Region
        • 7.2.4.1. South America
          • 7.2.4.1.1. Brazil
          • 7.2.4.1.2. Argentina
          • 7.2.4.1.3. Rest of South America
        • 7.2.4.2. Asia Pacific
          • 7.2.4.2.1. China
          • 7.2.4.2.2. Japan
          • 7.2.4.2.3. India
          • 7.2.4.2.4. South Korea
          • 7.2.4.2.5. Taiwan
          • 7.2.4.2.6. Australia
          • 7.2.4.2.7. Rest of Asia-Pacific
        • 7.2.4.3. Europe
          • 7.2.4.3.1. Germany
          • 7.2.4.3.2. France
          • 7.2.4.3.3. Italy
          • 7.2.4.3.4. United Kingdom
          • 7.2.4.3.5. Netherlands
          • 7.2.4.3.6. Rest of Europe
        • 7.2.4.4. MEA
          • 7.2.4.4.1. Middle East
          • 7.2.4.4.2. Africa
        • 7.2.4.5. North America
          • 7.2.4.5.1. United States
          • 7.2.4.5.2. Canada
          • 7.2.4.5.3. Mexico
    • 7.3. Global Medical Marijuana (Volume)
      • 7.3.1. Global Medical Marijuana by: Type (Volume)
        • 7.3.1.1. Buds
        • 7.3.1.2. Oil
        • 7.3.1.3. Tinctures
      • 7.3.2. Global Medical Marijuana by: Application (Volume)
        • 7.3.2.1. Chronic Pain
        • 7.3.2.2. Mental Disorders
        • 7.3.2.3. Arthritis
        • 7.3.2.4. Migraine
        • 7.3.2.5. Cancer
        • 7.3.2.6. Other
      • 7.3.3. Global Medical Marijuana by: Marijuana Type (Volume)
        • 7.3.3.1. Medical Marijuana
        • 7.3.3.2. Recreational Marijuana
      • 7.3.4. Global Medical Marijuana Region
        • 7.3.4.1. South America
          • 7.3.4.1.1. Brazil
          • 7.3.4.1.2. Argentina
          • 7.3.4.1.3. Rest of South America
        • 7.3.4.2. Asia Pacific
          • 7.3.4.2.1. China
          • 7.3.4.2.2. Japan
          • 7.3.4.2.3. India
          • 7.3.4.2.4. South Korea
          • 7.3.4.2.5. Taiwan
          • 7.3.4.2.6. Australia
          • 7.3.4.2.7. Rest of Asia-Pacific
        • 7.3.4.3. Europe
          • 7.3.4.3.1. Germany
          • 7.3.4.3.2. France
          • 7.3.4.3.3. Italy
          • 7.3.4.3.4. United Kingdom
          • 7.3.4.3.5. Netherlands
          • 7.3.4.3.6. Rest of Europe
        • 7.3.4.4. MEA
          • 7.3.4.4.1. Middle East
          • 7.3.4.4.2. Africa
        • 7.3.4.5. North America
          • 7.3.4.5.1. United States
          • 7.3.4.5.2. Canada
          • 7.3.4.5.3. Mexico
    • 7.4. Global Medical Marijuana (Price)
      • 7.4.1. Global Medical Marijuana by: Type (Price)
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Medical Marijuana: by Type(USD Million)
  • Table 2. Medical Marijuana Buds , by Region USD Million (2018-2023)
  • Table 3. Medical Marijuana Oil , by Region USD Million (2018-2023)
  • Table 4. Medical Marijuana Tinctures , by Region USD Million (2018-2023)
  • Table 5. Medical Marijuana: by Application(USD Million)
  • Table 6. Medical Marijuana Chronic Pain , by Region USD Million (2018-2023)
  • Table 7. Medical Marijuana Mental Disorders , by Region USD Million (2018-2023)
  • Table 8. Medical Marijuana Arthritis , by Region USD Million (2018-2023)
  • Table 9. Medical Marijuana Migraine , by Region USD Million (2018-2023)
  • Table 10. Medical Marijuana Cancer , by Region USD Million (2018-2023)
  • Table 11. Medical Marijuana Other , by Region USD Million (2018-2023)
  • Table 12. Medical Marijuana: by Marijuana Type(USD Million)
  • Table 13. Medical Marijuana Medical Marijuana , by Region USD Million (2018-2023)
  • Table 14. Medical Marijuana Recreational Marijuana , by Region USD Million (2018-2023)
  • Table 15. South America Medical Marijuana, by Country USD Million (2018-2023)
  • Table 16. South America Medical Marijuana, by Type USD Million (2018-2023)
  • Table 17. South America Medical Marijuana, by Application USD Million (2018-2023)
  • Table 18. South America Medical Marijuana, by Marijuana Type USD Million (2018-2023)
  • Table 19. Brazil Medical Marijuana, by Type USD Million (2018-2023)
  • Table 20. Brazil Medical Marijuana, by Application USD Million (2018-2023)
  • Table 21. Brazil Medical Marijuana, by Marijuana Type USD Million (2018-2023)
  • Table 22. Argentina Medical Marijuana, by Type USD Million (2018-2023)
  • Table 23. Argentina Medical Marijuana, by Application USD Million (2018-2023)
  • Table 24. Argentina Medical Marijuana, by Marijuana Type USD Million (2018-2023)
  • Table 25. Rest of South America Medical Marijuana, by Type USD Million (2018-2023)
  • Table 26. Rest of South America Medical Marijuana, by Application USD Million (2018-2023)
  • Table 27. Rest of South America Medical Marijuana, by Marijuana Type USD Million (2018-2023)
  • Table 28. Asia Pacific Medical Marijuana, by Country USD Million (2018-2023)
  • Table 29. Asia Pacific Medical Marijuana, by Type USD Million (2018-2023)
  • Table 30. Asia Pacific Medical Marijuana, by Application USD Million (2018-2023)
  • Table 31. Asia Pacific Medical Marijuana, by Marijuana Type USD Million (2018-2023)
  • Table 32. China Medical Marijuana, by Type USD Million (2018-2023)
  • Table 33. China Medical Marijuana, by Application USD Million (2018-2023)
  • Table 34. China Medical Marijuana, by Marijuana Type USD Million (2018-2023)
  • Table 35. Japan Medical Marijuana, by Type USD Million (2018-2023)
  • Table 36. Japan Medical Marijuana, by Application USD Million (2018-2023)
  • Table 37. Japan Medical Marijuana, by Marijuana Type USD Million (2018-2023)
  • Table 38. India Medical Marijuana, by Type USD Million (2018-2023)
  • Table 39. India Medical Marijuana, by Application USD Million (2018-2023)
  • Table 40. India Medical Marijuana, by Marijuana Type USD Million (2018-2023)
  • Table 41. South Korea Medical Marijuana, by Type USD Million (2018-2023)
  • Table 42. South Korea Medical Marijuana, by Application USD Million (2018-2023)
  • Table 43. South Korea Medical Marijuana, by Marijuana Type USD Million (2018-2023)
  • Table 44. Taiwan Medical Marijuana, by Type USD Million (2018-2023)
  • Table 45. Taiwan Medical Marijuana, by Application USD Million (2018-2023)
  • Table 46. Taiwan Medical Marijuana, by Marijuana Type USD Million (2018-2023)
  • Table 47. Australia Medical Marijuana, by Type USD Million (2018-2023)
  • Table 48. Australia Medical Marijuana, by Application USD Million (2018-2023)
  • Table 49. Australia Medical Marijuana, by Marijuana Type USD Million (2018-2023)
  • Table 50. Rest of Asia-Pacific Medical Marijuana, by Type USD Million (2018-2023)
  • Table 51. Rest of Asia-Pacific Medical Marijuana, by Application USD Million (2018-2023)
  • Table 52. Rest of Asia-Pacific Medical Marijuana, by Marijuana Type USD Million (2018-2023)
  • Table 53. Europe Medical Marijuana, by Country USD Million (2018-2023)
  • Table 54. Europe Medical Marijuana, by Type USD Million (2018-2023)
  • Table 55. Europe Medical Marijuana, by Application USD Million (2018-2023)
  • Table 56. Europe Medical Marijuana, by Marijuana Type USD Million (2018-2023)
  • Table 57. Germany Medical Marijuana, by Type USD Million (2018-2023)
  • Table 58. Germany Medical Marijuana, by Application USD Million (2018-2023)
  • Table 59. Germany Medical Marijuana, by Marijuana Type USD Million (2018-2023)
  • Table 60. France Medical Marijuana, by Type USD Million (2018-2023)
  • Table 61. France Medical Marijuana, by Application USD Million (2018-2023)
  • Table 62. France Medical Marijuana, by Marijuana Type USD Million (2018-2023)
  • Table 63. Italy Medical Marijuana, by Type USD Million (2018-2023)
  • Table 64. Italy Medical Marijuana, by Application USD Million (2018-2023)
  • Table 65. Italy Medical Marijuana, by Marijuana Type USD Million (2018-2023)
  • Table 66. United Kingdom Medical Marijuana, by Type USD Million (2018-2023)
  • Table 67. United Kingdom Medical Marijuana, by Application USD Million (2018-2023)
  • Table 68. United Kingdom Medical Marijuana, by Marijuana Type USD Million (2018-2023)
  • Table 69. Netherlands Medical Marijuana, by Type USD Million (2018-2023)
  • Table 70. Netherlands Medical Marijuana, by Application USD Million (2018-2023)
  • Table 71. Netherlands Medical Marijuana, by Marijuana Type USD Million (2018-2023)
  • Table 72. Rest of Europe Medical Marijuana, by Type USD Million (2018-2023)
  • Table 73. Rest of Europe Medical Marijuana, by Application USD Million (2018-2023)
  • Table 74. Rest of Europe Medical Marijuana, by Marijuana Type USD Million (2018-2023)
  • Table 75. MEA Medical Marijuana, by Country USD Million (2018-2023)
  • Table 76. MEA Medical Marijuana, by Type USD Million (2018-2023)
  • Table 77. MEA Medical Marijuana, by Application USD Million (2018-2023)
  • Table 78. MEA Medical Marijuana, by Marijuana Type USD Million (2018-2023)
  • Table 79. Middle East Medical Marijuana, by Type USD Million (2018-2023)
  • Table 80. Middle East Medical Marijuana, by Application USD Million (2018-2023)
  • Table 81. Middle East Medical Marijuana, by Marijuana Type USD Million (2018-2023)
  • Table 82. Africa Medical Marijuana, by Type USD Million (2018-2023)
  • Table 83. Africa Medical Marijuana, by Application USD Million (2018-2023)
  • Table 84. Africa Medical Marijuana, by Marijuana Type USD Million (2018-2023)
  • Table 85. North America Medical Marijuana, by Country USD Million (2018-2023)
  • Table 86. North America Medical Marijuana, by Type USD Million (2018-2023)
  • Table 87. North America Medical Marijuana, by Application USD Million (2018-2023)
  • Table 88. North America Medical Marijuana, by Marijuana Type USD Million (2018-2023)
  • Table 89. United States Medical Marijuana, by Type USD Million (2018-2023)
  • Table 90. United States Medical Marijuana, by Application USD Million (2018-2023)
  • Table 91. United States Medical Marijuana, by Marijuana Type USD Million (2018-2023)
  • Table 92. Canada Medical Marijuana, by Type USD Million (2018-2023)
  • Table 93. Canada Medical Marijuana, by Application USD Million (2018-2023)
  • Table 94. Canada Medical Marijuana, by Marijuana Type USD Million (2018-2023)
  • Table 95. Mexico Medical Marijuana, by Type USD Million (2018-2023)
  • Table 96. Mexico Medical Marijuana, by Application USD Million (2018-2023)
  • Table 97. Mexico Medical Marijuana, by Marijuana Type USD Million (2018-2023)
  • Table 98. Medical Marijuana Sales: by Type(Tons)
  • Table 99. Medical Marijuana Sales Buds , by Region Tons (2018-2023)
  • Table 100. Medical Marijuana Sales Oil , by Region Tons (2018-2023)
  • Table 101. Medical Marijuana Sales Tinctures , by Region Tons (2018-2023)
  • Table 102. Medical Marijuana Sales: by Application(Tons)
  • Table 103. Medical Marijuana Sales Chronic Pain , by Region Tons (2018-2023)
  • Table 104. Medical Marijuana Sales Mental Disorders , by Region Tons (2018-2023)
  • Table 105. Medical Marijuana Sales Arthritis , by Region Tons (2018-2023)
  • Table 106. Medical Marijuana Sales Migraine , by Region Tons (2018-2023)
  • Table 107. Medical Marijuana Sales Cancer , by Region Tons (2018-2023)
  • Table 108. Medical Marijuana Sales Other , by Region Tons (2018-2023)
  • Table 109. Medical Marijuana Sales: by Marijuana Type(Tons)
  • Table 110. Medical Marijuana Sales Medical Marijuana , by Region Tons (2018-2023)
  • Table 111. Medical Marijuana Sales Recreational Marijuana , by Region Tons (2018-2023)
  • Table 112. South America Medical Marijuana Sales, by Country Tons (2018-2023)
  • Table 113. South America Medical Marijuana Sales, by Type Tons (2018-2023)
  • Table 114. South America Medical Marijuana Sales, by Application Tons (2018-2023)
  • Table 115. South America Medical Marijuana Sales, by Marijuana Type Tons (2018-2023)
  • Table 116. Brazil Medical Marijuana Sales, by Type Tons (2018-2023)
  • Table 117. Brazil Medical Marijuana Sales, by Application Tons (2018-2023)
  • Table 118. Brazil Medical Marijuana Sales, by Marijuana Type Tons (2018-2023)
  • Table 119. Argentina Medical Marijuana Sales, by Type Tons (2018-2023)
  • Table 120. Argentina Medical Marijuana Sales, by Application Tons (2018-2023)
  • Table 121. Argentina Medical Marijuana Sales, by Marijuana Type Tons (2018-2023)
  • Table 122. Rest of South America Medical Marijuana Sales, by Type Tons (2018-2023)
  • Table 123. Rest of South America Medical Marijuana Sales, by Application Tons (2018-2023)
  • Table 124. Rest of South America Medical Marijuana Sales, by Marijuana Type Tons (2018-2023)
  • Table 125. Asia Pacific Medical Marijuana Sales, by Country Tons (2018-2023)
  • Table 126. Asia Pacific Medical Marijuana Sales, by Type Tons (2018-2023)
  • Table 127. Asia Pacific Medical Marijuana Sales, by Application Tons (2018-2023)
  • Table 128. Asia Pacific Medical Marijuana Sales, by Marijuana Type Tons (2018-2023)
  • Table 129. China Medical Marijuana Sales, by Type Tons (2018-2023)
  • Table 130. China Medical Marijuana Sales, by Application Tons (2018-2023)
  • Table 131. China Medical Marijuana Sales, by Marijuana Type Tons (2018-2023)
  • Table 132. Japan Medical Marijuana Sales, by Type Tons (2018-2023)
  • Table 133. Japan Medical Marijuana Sales, by Application Tons (2018-2023)
  • Table 134. Japan Medical Marijuana Sales, by Marijuana Type Tons (2018-2023)
  • Table 135. India Medical Marijuana Sales, by Type Tons (2018-2023)
  • Table 136. India Medical Marijuana Sales, by Application Tons (2018-2023)
  • Table 137. India Medical Marijuana Sales, by Marijuana Type Tons (2018-2023)
  • Table 138. South Korea Medical Marijuana Sales, by Type Tons (2018-2023)
  • Table 139. South Korea Medical Marijuana Sales, by Application Tons (2018-2023)
  • Table 140. South Korea Medical Marijuana Sales, by Marijuana Type Tons (2018-2023)
  • Table 141. Taiwan Medical Marijuana Sales, by Type Tons (2018-2023)
  • Table 142. Taiwan Medical Marijuana Sales, by Application Tons (2018-2023)
  • Table 143. Taiwan Medical Marijuana Sales, by Marijuana Type Tons (2018-2023)
  • Table 144. Australia Medical Marijuana Sales, by Type Tons (2018-2023)
  • Table 145. Australia Medical Marijuana Sales, by Application Tons (2018-2023)
  • Table 146. Australia Medical Marijuana Sales, by Marijuana Type Tons (2018-2023)
  • Table 147. Rest of Asia-Pacific Medical Marijuana Sales, by Type Tons (2018-2023)
  • Table 148. Rest of Asia-Pacific Medical Marijuana Sales, by Application Tons (2018-2023)
  • Table 149. Rest of Asia-Pacific Medical Marijuana Sales, by Marijuana Type Tons (2018-2023)
  • Table 150. Europe Medical Marijuana Sales, by Country Tons (2018-2023)
  • Table 151. Europe Medical Marijuana Sales, by Type Tons (2018-2023)
  • Table 152. Europe Medical Marijuana Sales, by Application Tons (2018-2023)
  • Table 153. Europe Medical Marijuana Sales, by Marijuana Type Tons (2018-2023)
  • Table 154. Germany Medical Marijuana Sales, by Type Tons (2018-2023)
  • Table 155. Germany Medical Marijuana Sales, by Application Tons (2018-2023)
  • Table 156. Germany Medical Marijuana Sales, by Marijuana Type Tons (2018-2023)
  • Table 157. France Medical Marijuana Sales, by Type Tons (2018-2023)
  • Table 158. France Medical Marijuana Sales, by Application Tons (2018-2023)
  • Table 159. France Medical Marijuana Sales, by Marijuana Type Tons (2018-2023)
  • Table 160. Italy Medical Marijuana Sales, by Type Tons (2018-2023)
  • Table 161. Italy Medical Marijuana Sales, by Application Tons (2018-2023)
  • Table 162. Italy Medical Marijuana Sales, by Marijuana Type Tons (2018-2023)
  • Table 163. United Kingdom Medical Marijuana Sales, by Type Tons (2018-2023)
  • Table 164. United Kingdom Medical Marijuana Sales, by Application Tons (2018-2023)
  • Table 165. United Kingdom Medical Marijuana Sales, by Marijuana Type Tons (2018-2023)
  • Table 166. Netherlands Medical Marijuana Sales, by Type Tons (2018-2023)
  • Table 167. Netherlands Medical Marijuana Sales, by Application Tons (2018-2023)
  • Table 168. Netherlands Medical Marijuana Sales, by Marijuana Type Tons (2018-2023)
  • Table 169. Rest of Europe Medical Marijuana Sales, by Type Tons (2018-2023)
  • Table 170. Rest of Europe Medical Marijuana Sales, by Application Tons (2018-2023)
  • Table 171. Rest of Europe Medical Marijuana Sales, by Marijuana Type Tons (2018-2023)
  • Table 172. MEA Medical Marijuana Sales, by Country Tons (2018-2023)
  • Table 173. MEA Medical Marijuana Sales, by Type Tons (2018-2023)
  • Table 174. MEA Medical Marijuana Sales, by Application Tons (2018-2023)
  • Table 175. MEA Medical Marijuana Sales, by Marijuana Type Tons (2018-2023)
  • Table 176. Middle East Medical Marijuana Sales, by Type Tons (2018-2023)
  • Table 177. Middle East Medical Marijuana Sales, by Application Tons (2018-2023)
  • Table 178. Middle East Medical Marijuana Sales, by Marijuana Type Tons (2018-2023)
  • Table 179. Africa Medical Marijuana Sales, by Type Tons (2018-2023)
  • Table 180. Africa Medical Marijuana Sales, by Application Tons (2018-2023)
  • Table 181. Africa Medical Marijuana Sales, by Marijuana Type Tons (2018-2023)
  • Table 182. North America Medical Marijuana Sales, by Country Tons (2018-2023)
  • Table 183. North America Medical Marijuana Sales, by Type Tons (2018-2023)
  • Table 184. North America Medical Marijuana Sales, by Application Tons (2018-2023)
  • Table 185. North America Medical Marijuana Sales, by Marijuana Type Tons (2018-2023)
  • Table 186. United States Medical Marijuana Sales, by Type Tons (2018-2023)
  • Table 187. United States Medical Marijuana Sales, by Application Tons (2018-2023)
  • Table 188. United States Medical Marijuana Sales, by Marijuana Type Tons (2018-2023)
  • Table 189. Canada Medical Marijuana Sales, by Type Tons (2018-2023)
  • Table 190. Canada Medical Marijuana Sales, by Application Tons (2018-2023)
  • Table 191. Canada Medical Marijuana Sales, by Marijuana Type Tons (2018-2023)
  • Table 192. Mexico Medical Marijuana Sales, by Type Tons (2018-2023)
  • Table 193. Mexico Medical Marijuana Sales, by Application Tons (2018-2023)
  • Table 194. Mexico Medical Marijuana Sales, by Marijuana Type Tons (2018-2023)
  • Table 195. Medical Marijuana: by Type(USD/Units)
  • Table 196. Company Basic Information, Sales Area and Its Competitors
  • Table 197. Company Basic Information, Sales Area and Its Competitors
  • Table 198. Company Basic Information, Sales Area and Its Competitors
  • Table 199. Company Basic Information, Sales Area and Its Competitors
  • Table 200. Company Basic Information, Sales Area and Its Competitors
  • Table 201. Company Basic Information, Sales Area and Its Competitors
  • Table 202. Company Basic Information, Sales Area and Its Competitors
  • Table 203. Company Basic Information, Sales Area and Its Competitors
  • Table 204. Company Basic Information, Sales Area and Its Competitors
  • Table 205. Medical Marijuana: by Type(USD Million)
  • Table 206. Medical Marijuana Buds , by Region USD Million (2025-2030)
  • Table 207. Medical Marijuana Oil , by Region USD Million (2025-2030)
  • Table 208. Medical Marijuana Tinctures , by Region USD Million (2025-2030)
  • Table 209. Medical Marijuana: by Application(USD Million)
  • Table 210. Medical Marijuana Chronic Pain , by Region USD Million (2025-2030)
  • Table 211. Medical Marijuana Mental Disorders , by Region USD Million (2025-2030)
  • Table 212. Medical Marijuana Arthritis , by Region USD Million (2025-2030)
  • Table 213. Medical Marijuana Migraine , by Region USD Million (2025-2030)
  • Table 214. Medical Marijuana Cancer , by Region USD Million (2025-2030)
  • Table 215. Medical Marijuana Other , by Region USD Million (2025-2030)
  • Table 216. Medical Marijuana: by Marijuana Type(USD Million)
  • Table 217. Medical Marijuana Medical Marijuana , by Region USD Million (2025-2030)
  • Table 218. Medical Marijuana Recreational Marijuana , by Region USD Million (2025-2030)
  • Table 219. South America Medical Marijuana, by Country USD Million (2025-2030)
  • Table 220. South America Medical Marijuana, by Type USD Million (2025-2030)
  • Table 221. South America Medical Marijuana, by Application USD Million (2025-2030)
  • Table 222. South America Medical Marijuana, by Marijuana Type USD Million (2025-2030)
  • Table 223. Brazil Medical Marijuana, by Type USD Million (2025-2030)
  • Table 224. Brazil Medical Marijuana, by Application USD Million (2025-2030)
  • Table 225. Brazil Medical Marijuana, by Marijuana Type USD Million (2025-2030)
  • Table 226. Argentina Medical Marijuana, by Type USD Million (2025-2030)
  • Table 227. Argentina Medical Marijuana, by Application USD Million (2025-2030)
  • Table 228. Argentina Medical Marijuana, by Marijuana Type USD Million (2025-2030)
  • Table 229. Rest of South America Medical Marijuana, by Type USD Million (2025-2030)
  • Table 230. Rest of South America Medical Marijuana, by Application USD Million (2025-2030)
  • Table 231. Rest of South America Medical Marijuana, by Marijuana Type USD Million (2025-2030)
  • Table 232. Asia Pacific Medical Marijuana, by Country USD Million (2025-2030)
  • Table 233. Asia Pacific Medical Marijuana, by Type USD Million (2025-2030)
  • Table 234. Asia Pacific Medical Marijuana, by Application USD Million (2025-2030)
  • Table 235. Asia Pacific Medical Marijuana, by Marijuana Type USD Million (2025-2030)
  • Table 236. China Medical Marijuana, by Type USD Million (2025-2030)
  • Table 237. China Medical Marijuana, by Application USD Million (2025-2030)
  • Table 238. China Medical Marijuana, by Marijuana Type USD Million (2025-2030)
  • Table 239. Japan Medical Marijuana, by Type USD Million (2025-2030)
  • Table 240. Japan Medical Marijuana, by Application USD Million (2025-2030)
  • Table 241. Japan Medical Marijuana, by Marijuana Type USD Million (2025-2030)
  • Table 242. India Medical Marijuana, by Type USD Million (2025-2030)
  • Table 243. India Medical Marijuana, by Application USD Million (2025-2030)
  • Table 244. India Medical Marijuana, by Marijuana Type USD Million (2025-2030)
  • Table 245. South Korea Medical Marijuana, by Type USD Million (2025-2030)
  • Table 246. South Korea Medical Marijuana, by Application USD Million (2025-2030)
  • Table 247. South Korea Medical Marijuana, by Marijuana Type USD Million (2025-2030)
  • Table 248. Taiwan Medical Marijuana, by Type USD Million (2025-2030)
  • Table 249. Taiwan Medical Marijuana, by Application USD Million (2025-2030)
  • Table 250. Taiwan Medical Marijuana, by Marijuana Type USD Million (2025-2030)
  • Table 251. Australia Medical Marijuana, by Type USD Million (2025-2030)
  • Table 252. Australia Medical Marijuana, by Application USD Million (2025-2030)
  • Table 253. Australia Medical Marijuana, by Marijuana Type USD Million (2025-2030)
  • Table 254. Rest of Asia-Pacific Medical Marijuana, by Type USD Million (2025-2030)
  • Table 255. Rest of Asia-Pacific Medical Marijuana, by Application USD Million (2025-2030)
  • Table 256. Rest of Asia-Pacific Medical Marijuana, by Marijuana Type USD Million (2025-2030)
  • Table 257. Europe Medical Marijuana, by Country USD Million (2025-2030)
  • Table 258. Europe Medical Marijuana, by Type USD Million (2025-2030)
  • Table 259. Europe Medical Marijuana, by Application USD Million (2025-2030)
  • Table 260. Europe Medical Marijuana, by Marijuana Type USD Million (2025-2030)
  • Table 261. Germany Medical Marijuana, by Type USD Million (2025-2030)
  • Table 262. Germany Medical Marijuana, by Application USD Million (2025-2030)
  • Table 263. Germany Medical Marijuana, by Marijuana Type USD Million (2025-2030)
  • Table 264. France Medical Marijuana, by Type USD Million (2025-2030)
  • Table 265. France Medical Marijuana, by Application USD Million (2025-2030)
  • Table 266. France Medical Marijuana, by Marijuana Type USD Million (2025-2030)
  • Table 267. Italy Medical Marijuana, by Type USD Million (2025-2030)
  • Table 268. Italy Medical Marijuana, by Application USD Million (2025-2030)
  • Table 269. Italy Medical Marijuana, by Marijuana Type USD Million (2025-2030)
  • Table 270. United Kingdom Medical Marijuana, by Type USD Million (2025-2030)
  • Table 271. United Kingdom Medical Marijuana, by Application USD Million (2025-2030)
  • Table 272. United Kingdom Medical Marijuana, by Marijuana Type USD Million (2025-2030)
  • Table 273. Netherlands Medical Marijuana, by Type USD Million (2025-2030)
  • Table 274. Netherlands Medical Marijuana, by Application USD Million (2025-2030)
  • Table 275. Netherlands Medical Marijuana, by Marijuana Type USD Million (2025-2030)
  • Table 276. Rest of Europe Medical Marijuana, by Type USD Million (2025-2030)
  • Table 277. Rest of Europe Medical Marijuana, by Application USD Million (2025-2030)
  • Table 278. Rest of Europe Medical Marijuana, by Marijuana Type USD Million (2025-2030)
  • Table 279. MEA Medical Marijuana, by Country USD Million (2025-2030)
  • Table 280. MEA Medical Marijuana, by Type USD Million (2025-2030)
  • Table 281. MEA Medical Marijuana, by Application USD Million (2025-2030)
  • Table 282. MEA Medical Marijuana, by Marijuana Type USD Million (2025-2030)
  • Table 283. Middle East Medical Marijuana, by Type USD Million (2025-2030)
  • Table 284. Middle East Medical Marijuana, by Application USD Million (2025-2030)
  • Table 285. Middle East Medical Marijuana, by Marijuana Type USD Million (2025-2030)
  • Table 286. Africa Medical Marijuana, by Type USD Million (2025-2030)
  • Table 287. Africa Medical Marijuana, by Application USD Million (2025-2030)
  • Table 288. Africa Medical Marijuana, by Marijuana Type USD Million (2025-2030)
  • Table 289. North America Medical Marijuana, by Country USD Million (2025-2030)
  • Table 290. North America Medical Marijuana, by Type USD Million (2025-2030)
  • Table 291. North America Medical Marijuana, by Application USD Million (2025-2030)
  • Table 292. North America Medical Marijuana, by Marijuana Type USD Million (2025-2030)
  • Table 293. United States Medical Marijuana, by Type USD Million (2025-2030)
  • Table 294. United States Medical Marijuana, by Application USD Million (2025-2030)
  • Table 295. United States Medical Marijuana, by Marijuana Type USD Million (2025-2030)
  • Table 296. Canada Medical Marijuana, by Type USD Million (2025-2030)
  • Table 297. Canada Medical Marijuana, by Application USD Million (2025-2030)
  • Table 298. Canada Medical Marijuana, by Marijuana Type USD Million (2025-2030)
  • Table 299. Mexico Medical Marijuana, by Type USD Million (2025-2030)
  • Table 300. Mexico Medical Marijuana, by Application USD Million (2025-2030)
  • Table 301. Mexico Medical Marijuana, by Marijuana Type USD Million (2025-2030)
  • Table 302. Medical Marijuana Sales: by Type(Tons)
  • Table 303. Medical Marijuana Sales Buds , by Region Tons (2025-2030)
  • Table 304. Medical Marijuana Sales Oil , by Region Tons (2025-2030)
  • Table 305. Medical Marijuana Sales Tinctures , by Region Tons (2025-2030)
  • Table 306. Medical Marijuana Sales: by Application(Tons)
  • Table 307. Medical Marijuana Sales Chronic Pain , by Region Tons (2025-2030)
  • Table 308. Medical Marijuana Sales Mental Disorders , by Region Tons (2025-2030)
  • Table 309. Medical Marijuana Sales Arthritis , by Region Tons (2025-2030)
  • Table 310. Medical Marijuana Sales Migraine , by Region Tons (2025-2030)
  • Table 311. Medical Marijuana Sales Cancer , by Region Tons (2025-2030)
  • Table 312. Medical Marijuana Sales Other , by Region Tons (2025-2030)
  • Table 313. Medical Marijuana Sales: by Marijuana Type(Tons)
  • Table 314. Medical Marijuana Sales Medical Marijuana , by Region Tons (2025-2030)
  • Table 315. Medical Marijuana Sales Recreational Marijuana , by Region Tons (2025-2030)
  • Table 316. South America Medical Marijuana Sales, by Country Tons (2025-2030)
  • Table 317. South America Medical Marijuana Sales, by Type Tons (2025-2030)
  • Table 318. South America Medical Marijuana Sales, by Application Tons (2025-2030)
  • Table 319. South America Medical Marijuana Sales, by Marijuana Type Tons (2025-2030)
  • Table 320. Brazil Medical Marijuana Sales, by Type Tons (2025-2030)
  • Table 321. Brazil Medical Marijuana Sales, by Application Tons (2025-2030)
  • Table 322. Brazil Medical Marijuana Sales, by Marijuana Type Tons (2025-2030)
  • Table 323. Argentina Medical Marijuana Sales, by Type Tons (2025-2030)
  • Table 324. Argentina Medical Marijuana Sales, by Application Tons (2025-2030)
  • Table 325. Argentina Medical Marijuana Sales, by Marijuana Type Tons (2025-2030)
  • Table 326. Rest of South America Medical Marijuana Sales, by Type Tons (2025-2030)
  • Table 327. Rest of South America Medical Marijuana Sales, by Application Tons (2025-2030)
  • Table 328. Rest of South America Medical Marijuana Sales, by Marijuana Type Tons (2025-2030)
  • Table 329. Asia Pacific Medical Marijuana Sales, by Country Tons (2025-2030)
  • Table 330. Asia Pacific Medical Marijuana Sales, by Type Tons (2025-2030)
  • Table 331. Asia Pacific Medical Marijuana Sales, by Application Tons (2025-2030)
  • Table 332. Asia Pacific Medical Marijuana Sales, by Marijuana Type Tons (2025-2030)
  • Table 333. China Medical Marijuana Sales, by Type Tons (2025-2030)
  • Table 334. China Medical Marijuana Sales, by Application Tons (2025-2030)
  • Table 335. China Medical Marijuana Sales, by Marijuana Type Tons (2025-2030)
  • Table 336. Japan Medical Marijuana Sales, by Type Tons (2025-2030)
  • Table 337. Japan Medical Marijuana Sales, by Application Tons (2025-2030)
  • Table 338. Japan Medical Marijuana Sales, by Marijuana Type Tons (2025-2030)
  • Table 339. India Medical Marijuana Sales, by Type Tons (2025-2030)
  • Table 340. India Medical Marijuana Sales, by Application Tons (2025-2030)
  • Table 341. India Medical Marijuana Sales, by Marijuana Type Tons (2025-2030)
  • Table 342. South Korea Medical Marijuana Sales, by Type Tons (2025-2030)
  • Table 343. South Korea Medical Marijuana Sales, by Application Tons (2025-2030)
  • Table 344. South Korea Medical Marijuana Sales, by Marijuana Type Tons (2025-2030)
  • Table 345. Taiwan Medical Marijuana Sales, by Type Tons (2025-2030)
  • Table 346. Taiwan Medical Marijuana Sales, by Application Tons (2025-2030)
  • Table 347. Taiwan Medical Marijuana Sales, by Marijuana Type Tons (2025-2030)
  • Table 348. Australia Medical Marijuana Sales, by Type Tons (2025-2030)
  • Table 349. Australia Medical Marijuana Sales, by Application Tons (2025-2030)
  • Table 350. Australia Medical Marijuana Sales, by Marijuana Type Tons (2025-2030)
  • Table 351. Rest of Asia-Pacific Medical Marijuana Sales, by Type Tons (2025-2030)
  • Table 352. Rest of Asia-Pacific Medical Marijuana Sales, by Application Tons (2025-2030)
  • Table 353. Rest of Asia-Pacific Medical Marijuana Sales, by Marijuana Type Tons (2025-2030)
  • Table 354. Europe Medical Marijuana Sales, by Country Tons (2025-2030)
  • Table 355. Europe Medical Marijuana Sales, by Type Tons (2025-2030)
  • Table 356. Europe Medical Marijuana Sales, by Application Tons (2025-2030)
  • Table 357. Europe Medical Marijuana Sales, by Marijuana Type Tons (2025-2030)
  • Table 358. Germany Medical Marijuana Sales, by Type Tons (2025-2030)
  • Table 359. Germany Medical Marijuana Sales, by Application Tons (2025-2030)
  • Table 360. Germany Medical Marijuana Sales, by Marijuana Type Tons (2025-2030)
  • Table 361. France Medical Marijuana Sales, by Type Tons (2025-2030)
  • Table 362. France Medical Marijuana Sales, by Application Tons (2025-2030)
  • Table 363. France Medical Marijuana Sales, by Marijuana Type Tons (2025-2030)
  • Table 364. Italy Medical Marijuana Sales, by Type Tons (2025-2030)
  • Table 365. Italy Medical Marijuana Sales, by Application Tons (2025-2030)
  • Table 366. Italy Medical Marijuana Sales, by Marijuana Type Tons (2025-2030)
  • Table 367. United Kingdom Medical Marijuana Sales, by Type Tons (2025-2030)
  • Table 368. United Kingdom Medical Marijuana Sales, by Application Tons (2025-2030)
  • Table 369. United Kingdom Medical Marijuana Sales, by Marijuana Type Tons (2025-2030)
  • Table 370. Netherlands Medical Marijuana Sales, by Type Tons (2025-2030)
  • Table 371. Netherlands Medical Marijuana Sales, by Application Tons (2025-2030)
  • Table 372. Netherlands Medical Marijuana Sales, by Marijuana Type Tons (2025-2030)
  • Table 373. Rest of Europe Medical Marijuana Sales, by Type Tons (2025-2030)
  • Table 374. Rest of Europe Medical Marijuana Sales, by Application Tons (2025-2030)
  • Table 375. Rest of Europe Medical Marijuana Sales, by Marijuana Type Tons (2025-2030)
  • Table 376. MEA Medical Marijuana Sales, by Country Tons (2025-2030)
  • Table 377. MEA Medical Marijuana Sales, by Type Tons (2025-2030)
  • Table 378. MEA Medical Marijuana Sales, by Application Tons (2025-2030)
  • Table 379. MEA Medical Marijuana Sales, by Marijuana Type Tons (2025-2030)
  • Table 380. Middle East Medical Marijuana Sales, by Type Tons (2025-2030)
  • Table 381. Middle East Medical Marijuana Sales, by Application Tons (2025-2030)
  • Table 382. Middle East Medical Marijuana Sales, by Marijuana Type Tons (2025-2030)
  • Table 383. Africa Medical Marijuana Sales, by Type Tons (2025-2030)
  • Table 384. Africa Medical Marijuana Sales, by Application Tons (2025-2030)
  • Table 385. Africa Medical Marijuana Sales, by Marijuana Type Tons (2025-2030)
  • Table 386. North America Medical Marijuana Sales, by Country Tons (2025-2030)
  • Table 387. North America Medical Marijuana Sales, by Type Tons (2025-2030)
  • Table 388. North America Medical Marijuana Sales, by Application Tons (2025-2030)
  • Table 389. North America Medical Marijuana Sales, by Marijuana Type Tons (2025-2030)
  • Table 390. United States Medical Marijuana Sales, by Type Tons (2025-2030)
  • Table 391. United States Medical Marijuana Sales, by Application Tons (2025-2030)
  • Table 392. United States Medical Marijuana Sales, by Marijuana Type Tons (2025-2030)
  • Table 393. Canada Medical Marijuana Sales, by Type Tons (2025-2030)
  • Table 394. Canada Medical Marijuana Sales, by Application Tons (2025-2030)
  • Table 395. Canada Medical Marijuana Sales, by Marijuana Type Tons (2025-2030)
  • Table 396. Mexico Medical Marijuana Sales, by Type Tons (2025-2030)
  • Table 397. Mexico Medical Marijuana Sales, by Application Tons (2025-2030)
  • Table 398. Mexico Medical Marijuana Sales, by Marijuana Type Tons (2025-2030)
  • Table 399. Medical Marijuana: by Type(USD/Units)
  • Table 400. Research Programs/Design for This Report
  • Table 401. Key Data Information from Secondary Sources
  • Table 402. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Medical Marijuana: by Type USD Million (2018-2023)
  • Figure 5. Global Medical Marijuana: by Application USD Million (2018-2023)
  • Figure 6. Global Medical Marijuana: by Marijuana Type USD Million (2018-2023)
  • Figure 7. South America Medical Marijuana Share (%), by Country
  • Figure 8. Asia Pacific Medical Marijuana Share (%), by Country
  • Figure 9. Europe Medical Marijuana Share (%), by Country
  • Figure 10. MEA Medical Marijuana Share (%), by Country
  • Figure 11. North America Medical Marijuana Share (%), by Country
  • Figure 12. Global Medical Marijuana: by Type Tons (2018-2023)
  • Figure 13. Global Medical Marijuana: by Application Tons (2018-2023)
  • Figure 14. Global Medical Marijuana: by Marijuana Type Tons (2018-2023)
  • Figure 15. South America Medical Marijuana Share (%), by Country
  • Figure 16. Asia Pacific Medical Marijuana Share (%), by Country
  • Figure 17. Europe Medical Marijuana Share (%), by Country
  • Figure 18. MEA Medical Marijuana Share (%), by Country
  • Figure 19. North America Medical Marijuana Share (%), by Country
  • Figure 20. Global Medical Marijuana: by Type USD/Units (2018-2023)
  • Figure 21. Global Medical Marijuana share by Players 2023 (%)
  • Figure 22. Global Medical Marijuana share by Players (Top 3) 2023(%)
  • Figure 23. Global Medical Marijuana share by Players (Top 5) 2023(%)
  • Figure 24. BCG Matrix for key Companies
  • Figure 25. GW Pharmaceuticals PLC. (United Kingdom) Revenue, Net Income and Gross profit
  • Figure 26. GW Pharmaceuticals PLC. (United Kingdom) Revenue: by Geography 2023
  • Figure 27. MedReleaf Corporation (Canada) Revenue, Net Income and Gross profit
  • Figure 28. MedReleaf Corporation (Canada) Revenue: by Geography 2023
  • Figure 29. Canopy Growth Corporation (Canada) Revenue, Net Income and Gross profit
  • Figure 30. Canopy Growth Corporation (Canada) Revenue: by Geography 2023
  • Figure 31. Aphria Incorporation (Canada) Revenue, Net Income and Gross profit
  • Figure 32. Aphria Incorporation (Canada) Revenue: by Geography 2023
  • Figure 33. Aurora Cannabis Inc. (Canada) Revenue, Net Income and Gross profit
  • Figure 34. Aurora Cannabis Inc. (Canada) Revenue: by Geography 2023
  • Figure 35. Medical Marijuana, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 36. Medical Marijuana, Inc. (United States) Revenue: by Geography 2023
  • Figure 37. Green Relief Inc. (Canada) Revenue, Net Income and Gross profit
  • Figure 38. Green Relief Inc. (Canada) Revenue: by Geography 2023
  • Figure 39. Cannabis Sativa, INC. (United States) Revenue, Net Income and Gross profit
  • Figure 40. Cannabis Sativa, INC. (United States) Revenue: by Geography 2023
  • Figure 41. Insys Therapeutics, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 42. Insys Therapeutics, Inc. (United States) Revenue: by Geography 2023
  • Figure 43. Global Medical Marijuana: by Type USD Million (2025-2030)
  • Figure 44. Global Medical Marijuana: by Application USD Million (2025-2030)
  • Figure 45. Global Medical Marijuana: by Marijuana Type USD Million (2025-2030)
  • Figure 46. South America Medical Marijuana Share (%), by Country
  • Figure 47. Asia Pacific Medical Marijuana Share (%), by Country
  • Figure 48. Europe Medical Marijuana Share (%), by Country
  • Figure 49. MEA Medical Marijuana Share (%), by Country
  • Figure 50. North America Medical Marijuana Share (%), by Country
  • Figure 51. Global Medical Marijuana: by Type Tons (2025-2030)
  • Figure 52. Global Medical Marijuana: by Application Tons (2025-2030)
  • Figure 53. Global Medical Marijuana: by Marijuana Type Tons (2025-2030)
  • Figure 54. South America Medical Marijuana Share (%), by Country
  • Figure 55. Asia Pacific Medical Marijuana Share (%), by Country
  • Figure 56. Europe Medical Marijuana Share (%), by Country
  • Figure 57. MEA Medical Marijuana Share (%), by Country
  • Figure 58. North America Medical Marijuana Share (%), by Country
  • Figure 59. Global Medical Marijuana: by Type USD/Units (2025-2030)
List of companies from research coverage that are profiled in the study
  • GW Pharmaceuticals PLC. (United Kingdom)
  • MedReleaf Corporation (Canada)
  • Canopy Growth Corporation (Canada)
  • Aphria Incorporation (Canada)
  • Aurora Cannabis Inc. (Canada)
  • Medical Marijuana, Inc. (United States)
  • Green Relief Inc. (Canada)
  • Cannabis Sativa, INC. (United States)
  • Insys Therapeutics, Inc. (United States)
Additional players considered in the study are as follows:
Maricann Group, Inc. (Canada) , Tilray (Canada) , The Cronos Group (Canada) , Organigram Holdings, Inc. (Canada)
Select User Access Type

Key Highlights of Report


Apr 2024 237 Pages 82 Tables Base Year: 2023 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global Medical Marijuana Market research Quantitative research analysis
Global Medical Marijuana Market research Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

The standard version of the report profiles players such as GW Pharmaceuticals PLC. (United Kingdom), MedReleaf Corporation (Canada), Canopy Growth Corporation (Canada), Aphria Incorporation (Canada), Aurora Cannabis Inc. (Canada), Medical Marijuana, Inc. (United States), Green Relief Inc. (Canada), Cannabis Sativa, INC. (United States) and Insys Therapeutics, Inc. (United States) etc.
The Study can be customized subject to feasibility and data availability. Please connect with our sales representative for further information.
"Emergence of Luxury Cannabis Products " is seen as one of major influencing trends for Medical Marijuana Market during projected period 2023-2030.
The Medical Marijuana market study includes a random mix of players, including both market leaders and some top growing emerging players. Connect with our sales executive to get a complete company list in our research coverage.

Know More About Global Medical Marijuana Market research Report?

Have a Query? Click Here

Other Related Reports

Orphan Drugs Comprehensive Study by Drug Type (Biologics, Non-Biologics), Sale (Generics, Prescribed), Drugs (Revlimid, Rituxan, Opdivo, Others), Disease Type (Oncology, Gastrointestinal, Pulmonary, ...
$ 3750
Diptheria Vaccine Comprehensive Study by Type (Daptacel, Infanrix, Kinrix, Pediarix, Pentacel, Quaracel), Disease Type (Diphtheria, Tetanus, Pertussis), Packaging Type (0.5 ML, 1 ML, 2 ML, Others), A...
$ 3450
Bio-pharma Comprehensive Study by Type (Monoclonal Antibodies, Recombinant Proteins, Granulocyte-Colony Stimulating Factor (G-CSF), Interferons, Recombinant Human Insulin, Erythropoietin, Vaccines, G...
$ 3750
Polio Vaccines Comprehensive Study by Type (IPV (Inactivated Poliovirus Vaccine), OPV (Oral Polio Vaccine)), Application (Hospital, Clinics, Public Services, Others) Players and Region - Global Marke...
$ 3500
Impetigo Drug Comprehensive Study by Type (FMX-102, LTX-109, Mupirocin, Ozenoxacin, Others), Route of Administration (Topical, Oral), Distribution Channel (Hospital Pharmacy, Online Pharmacy, Retail ...
$ 3500
Clomifene Citrate Comprehensive Study by Application (Hospital, Clinics, Fertility Center), Form (Tablet, Injection), Distribution Channel (Hospital Pharmacies, Medical Stores, Online Pharmacies), En...
$ 3800